9 results on '"Abderrazek, Bouzouita"'
Search Results
2. Urological activity at the time of COVID-19 pandemic: Is there any differences between public and private field?
- Author
-
Skander Zouari, Ahmed Saadi, Marouene Chakroun, Amine Oueslati, Marwa Fliss, Abderrazek Bouzouita, Amine Derouiche, Riadh Ben Slama, Haroun Ayed, and Mohamed Chebil
- Subjects
covid-19 ,pandemics ,urology ,urological activity ,impact ,Medicine - Abstract
INTRODUCTION: As COVID-19 pandemic is rapidly evolving, there is a whole reorganization in hospitals to concentrate more resources to face the crisis. The purpose of this study is to evaluate the impact of COVID-19 disease on urological activity in Tunisia. To assess the differences in the management of urological conditions between the private and the public field. METHODS: a survey was addressed to all certified urologists working in Tunisia in both the public and private sectors (n=194) using the national database of active urologists available and updated. We either called them or looked them up through email or social media. The form was open from March the 28th to April the 3rd. Results were obtained via spreadsheet and analysed using SPSS 23.0. RESULTS: one hundred and twenty urologists have filled in the form. Consultations at the outpatient office were restricted to urgent cases in 66% (n=79). Telemedicine was more used by urologists in private than in public field p=0,03. Urologists in private sector followed more the sterilization protocol of the hospital/clinic and used more disposable materials whenever possible p=0,011. Elective surgical activity has completely stopped in 85% of the responders (n=102). Elective surgery requiring transfusion or intensive care unit was performed in 38% (n=46) and 26% (n=31) if there was a risk of disease progression. BPH surgery was more performed as usual in private sector than in public sector p=0,012. It was the only condition managed differently between both sectors. CONCLUSION: the drop of the urological activity is essential in order to give relevant stakeholders room to act efficiently against the spread of the virus. The context of the pandemic and the hospital´s condition must be taken into consideration without compromising the patient´s outcome.
- Published
- 2020
- Full Text
- View/download PDF
3. Ureteral stump empyema with calculi
- Author
-
Walid Smeoui, Ahmed Samet, Talel Touaiti, Nouri Rebai, Abderrazek Bouzouita, and Mourad Hadjslimène
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
A 52-year-old man with a history of right nephrectomy for a nonfunctioning kidney, consults after 22 years for fever with right lower abdominal pain. Surgical exploration was thereafter performed and the right ureteral stump was removed en bloc. Pathological examination of the right ureterectomy specimen revealed a significant acute and chronic ureteritis due to stone without any signs of malignancy. Owing to the low incidence of complications associated with ureteral stump, we suggest that if ureteral remnant becomes symptomatic, a distal ureterectomy should be performed without any delay avoiding subsequent complications of the stump.
- Published
- 2020
- Full Text
- View/download PDF
4. Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial
- Author
-
Ali Jendoubi, Wafa Aissi, Ahmed Abbes, Abderrazek Bouzouita, Sami Fourati, Hatem Necib, Salma Ghedira, and Mohamed Houissa
- Subjects
Analgesia ,catheter-related bladder discomfort ,intravenous parecoxib ,transurethral resection of bladder tumor ,Anesthesiology ,RD78.3-87.3 - Abstract
Background and Aims: Catheter-related bladder discomfort (CRBD) is the urge to void or discomfort in the suprapubic region secondary to an indwelling urinary catheter. We aimed to evaluate the safety and efficacy of single-dose of intravenous parecoxib in reducing the incidence and severity of CRBD in patients undergoing transurethral resection of bladder tumor (TURBT). Methods: Sixty-one adult patients, American Society of Anesthesiologists physical status I or II, undergoing elective TURBT under spinal anaesthesia, were randomly allocated to receive 40 mg of IV parecoxib (group P; n = 29) or an equal volume of normal saline (control group C; n = 32). CRBD was graded as none, mild, moderate, and severe. Between-group comparisons were made for the incidence and severity of CRBD, postoperative Visual analog scales (VAS), rescue analgesia equirements, and occurrence of adverse events. Statistical analysis done with the Mann–Whitney U-test and Fisher's Exact Test. A P value of ≤ 0.05 was considered statistically significant. Results: Parecoxib significantly reduced the incidence and severity of CRBD at 2, 4, 6, and 12 hours postoperatively compared to placebo (P < 0.05). Median pain VAS scores were lower in the P group at all times except the first hour. Rescue analgesia was given to more patients in group C (16/32, 50%) than in group P (1/29) (P < 0.001). None of the patients who received parecoxib experienced an adverse event. Conclusion: A single intravenous injection of parecoxib is safe and effective in decreasing the incidence and severity of CRBD in patients undergoing TURBT. Trial Registration Identifier: NCT02729935(www.clinicaltrials.gov).
- Published
- 2018
- Full Text
- View/download PDF
5. MP22-01 PREDICTIVE FACTORS OF RECURRENCE OF URETHRAL STRICTURES AFTER A FIRST INTERNAL URETROTOMY
- Author
-
Skander Zouari, Saadi Ahmed, Marouene Chakroun, Selim Zaghbib, Setti Boubaker Nouha, Hamza Boussaffa, Abderrazek Bouzouita, Amine Derouiche, Riadh Ben Slama, Haroun Ayed, and Mohamed Chebil
- Subjects
Urology - Published
- 2022
- Full Text
- View/download PDF
6. MP40-09 THE SYSTEMIC IMMUNE–INFLAMMATION INDEX (SII) AS PREDICTOR FACTOR OF SURVIVAL IN PATIENTS UNDERGOING RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA
- Author
-
Skander Zouari, Saadi Ahmed, Setti Boubaker Nouha, Bilel Saidani, Marouene Chakroun, Khadija Medddeb, Mouna Ayadi, Meriem Ksontini, Ahlem Blel, Hamza Boussaffa, Abderrazek Bouzouita, Amine Derouiche, Riadh Ben Slama, Ksontini Feriel, Amel Mezlini, Soumaya Rammeh, Haroun Ayed, and Mohamed Chebil
- Subjects
Urology - Published
- 2022
- Full Text
- View/download PDF
7. State of the art: Open prostatectomy for benign prostate hyperplasia: Should we avoid it in all cases?
- Author
-
Marouene, Chakroun, Skander, Zouari, Ahmed, Saadi, Hamza, Boussafa, Abderrazek, Bouzouita, Amine, Derouiche, Riadh, Ben Slama, Haroun, Ayed, and Mohamed, Chebil
- Subjects
Male ,Prostatectomy ,Cost-Benefit Analysis ,Prostatic Hyperplasia ,Humans ,Minimally Invasive Surgical Procedures ,Length of Stay - Abstract
Surgical procedures for benign prostate hyperplasia (BPH) had considerably evolved during last decades. New techniques can nowadays treat prostate big in size, which are classically treated by open prostatectomy (OP). Therefore, the place of this procedure that has been used for over 150 years is nowadays questioned. Is it outdated? Is there emerging techniques that are more efficient, safer and cost effective? This state of the art based on literature review will assess the place of OP in BPH surgery from efficacy on functional outcomes, security, competitiveness with modern and minimally invasive techniques and socio-economic perspectives. Currently, OP has excellent functional outcomes, with low rate of retreatment after surgery, low morbidity and affordable cost in our country. It remains competitive with new surgery techniques for BPH, even if the latter offer the advantages of a minimally invasive surgery, especially in hospitalization length. Taking in consideration the social and economic context in Tunisia, it remains the most accessible and affordable surgical technique. Besides, OP is a procedure that has to be handled by every urologist given the theoretical risk of conversion during endoscopic surgery of BPH, and its use under certain circumstances (In case of bladder lithiasis ou diverticle or impossibility of lithotomy position).
- Published
- 2021
8. Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018
- Author
-
J, Aarab, Ibtissem, Abbess, Fathi, Abdalla, Z, Abdelaziz, S, Abdelfattah, I, Abdelli, K, Abdelmajid, Zied, Abdelsselem, N, Abdelwahed, Nihed, Abdessayed, Bassem, Abid, K, Abid, R, Abidi, Asma, Abudabbous, Sana, Abujanah, Afaf, Aburwais, E, Acacha, Nessrine, Acharfi, Nejmeddine, Affes, R, Aftis, I, Ahalli, Mr, Aid, D, Aissaoui, A, Alaoui, M, Alaoui, Salaheddin, Albatran, Aldehmani, Mamdouh, Rabia, Alkikkli, A, Allam, S, Aloulou, Omar, Alqawi, Mussa A, Alragig, Ali, Alsharksi, K Oualla L, Amaadour, L, Amaadour, N, Ameziane, A, Ammari, H, Ammour, R, Amrane, N, Annad, E, Aouati, S, Aouichat, S, Aouragh, S, Arifi, Md, Astra, M, Atassi, Nidhal, Ati, K, Atoui, L, Atreche, S, Ayachi, I, Ayadi, Mohammed Ali, Ayadi, Mouna, Ayadi, Jihene, Ayari, Haroun, Ayed, K, Ayed, Henda, Ayedi, Ines, Ayedi, M, Azegrar, Heifa, Azzouz, Fathi, Babdalla, R, Bachiri, Z, Bachiri, M, Baghdad, R, Bahloul, A, Bahouli, M, Bahri, I, Baississ, Hanae, Bakkali, Mehdi, Balti, O, Baraket, Hayfa, Bargaoui, Rim, Batti, Ahlem, Bedioui, R, Begag, Z, Behourah, Imtinene, Belaid, Asma, Belaïd, Amine, Ben Abdallah, Ichrak, Ben Abdallah, Slim, Ben Ahmed, Tarek, Ben Ahmed, M, Ben Azaiz, M A, Ben Chehida, Leila, Ben Fatma, D, Ben Ghachem, T, Ben Ghachem, J, Ben Hassouna, S, Ben Hmida, Sonia, Ben Nasr, Dalel, Ben Nejima, K, Ben Rahal, M, Ben Rejeb, S, Ben Rhouma, I, Ben Safta, A, Ben Salem, Yosr, Ben Zargouna, Ichrak, Benabdallah, H, Benabdella, Mohamed Zied, Benabdessalem, Khaled, Benahmed, Slim, Benahmed, Hazem, Benameur, S, Benasr, Fz, Benbrahim, W, Benbrahim, Z, Benbrahim, Ma, Benchehida, Yasser, Bencheikh, Tarek, Bendhiab, Leila, Benfatma, A, Bengueddach, M, Benhami, Jamel, Benhassouna, W, Benhbib, Noureddine, Benjaafar, R, Benkali, Wala, Benkridis, A, Benlaloui, Mahmoud, Benmaitig, A, Benmansour, M, Benmouhoub, Farouk, Benna, H, Benna, Marouan, Benna, Mehdi, Benna, H, Bennabdellah, Khaled, Benrahal, Ines, Bensafta, Hanène, Bensalah, A, Bensalem, Mohammed, Bensaud, Riadh, Benslama, M, Benyoub, K, Benzid, H, Bergaoui, M, Beroual, S, Berrad, Y, Berrazaga, Z, Bezzaz, Hanene, Bhiri, M, Bibi, Mohamed Yassine, Binous, Ahlem, Blel, Jamela M, Boder, N, Bouaouina, Hanen, Bouaziz, S, Bouchoucha, Tahia, Boudawara, Zaher, Boudawara, A, Bouderbala, Rima, Bouhali, Malek, Bouhani, R, Boujarnija, Salah, Boujelben, Nadia, Boujelbene, I, Boukerzaza, H, Boukhari, W, Boulfoul, R, Boulma, N, Boumansour, A, Bouned, A, Bounedjar, I, Bouraoui, Saadia, Bouraoui, Rym, Bourigua, M, Bourmech, Hamza, Bousaffa, A, Bousahba, C, Bousrih, A, Boussarsar, Hammouda, Boussen, Selwa, Boutayeb, Khaled, Bouzaidi, Faten, Bouzaiene, H, Bouzaiene, Z, Bouzerzour, Kamel, Bouzid, N, Bouzid, Dw, Bouzidi, W, Bouzidi, Abderrazek, Bouzouita, S, Brahimi, A, Brahmia, Abdelbaset, Buhmeida, Kais, Chaaben, Hatem, Chaabouni, Mohamed, Chaabouni, Kais, Chaabène, H, Chaari, Ines, Chaari, M, Chaari, Imene, Chabchoub, K, Chabeene, K, Chaker, Marouene, Chakroun, M, Charfi, Slim, Charfi, R, Chargui, Md, Charles, Mohamed, Chebil, Khadidja, Cheikchouk, Beya, Chelly, Ines, Chelly, N, Cheraiet, Aziz, Cherif, Mohamed, Cherif, A, Cherifi, T, Chikhrouhou, A, Chikouche, A, Chirouf, Nesrine, Chraiet, Y, Collan, Zhanglin, Cui, Habiba, Dabbebi, Amira, Daldoul, I, Damouche, H, Daoud, N, Daoud, J, Daoued, Khadija, Darif, Dalia O, Darwish, Z, Derbouz, Amine, Derouiche, T T, Dhibe, Tarek, Dhibet, A, Djallaoui, N, Djami, K, Djebbes, H, Djedi, S, Djeghim, L, Djellali, A, Djellaoui, K, Djilat, R, Djouabi, H, Doumbia, Mustafa, Drah, M, Dridi, Mohamed, Hsairi, S, Elabbassi, Fz, Elallia, Zohra, Elati, M, Elattassi, Houda, Elbenna, Mohamed A, Elfagieh, Omran, Elfaitori, Hebatallah, Elfannas, Amine, Elghali, Mohamed Amine, Elghali, Salah, Elgonti, O Elamine, Elhadj, R, Elhazzaz, H, Elkacemi, Khaoula, Elkinany, Youssri, Elkissi, F, Elloumi, Olfa, Elmaalel, I S, Elmajjaou, S, Elmajjaoui, H, Elmhabrech, Fz, Elmrabet, Wesam A, Elsaghayer, Adam, Elzagheid, Fatma, Emaetig, H, Erraichi, Mejda, Essid, Nada, Ewshah, Faten, Ezzairi, Raja, Faleh, Sourour, Fallah, Amr Lotfy, Farag, L, Farhat, R, Fehri, Jihène, Feki, Sami, Fendri, Sana, Fendri, Z, Fessi, Taha, Filali, A, Fissah, M, Fourati, N, Fourati, Mounir, Frikha, C S, Fuchs, Azza, Gabssi, F, Gachi, Selma, Gadria, A, Gammoudi, I, Ganzoui, Asma, Gargoura, Imen, Ghaddabb, Imen, Gharbi, Maroua, Gharbi, E, Ghazouani, N, Gheriani, Abdelmonom, Ghorbel, L, Ghorbel, A, Ghozi, Rafik, Ghrissi, Amine, Gouader, A, Goucha, A, Guebsi, I, Guellil, Fatma, Guermazi, Sondess, Guesmi, Wafa, Guetari, N, Habak, A, Haddad, S, Haddad, Abderrazek, Haddaoui, I, Hadef, Abdelbasit Faraj, Hader, A, Hadiji, F, Hadjarab, Myriam, Hadoussa, Nadia, Hadoussa, Ch, Hafsa, Mariem, Hafsia, Ahmed, Hajji, M, Hajmansour, S, Hamdi, Z, Hamici, S, Hamida, Fehmi, Hamila, Selim, Hamissa, Boussen, Hammouda, Slim, Haouet, I, Harhira, Ayed, Haroun, K, Hassouni, A, Hdiji, Monia, Hechiche, L, Hejjane, C, Hellal, Manseurs, Henni, K, Herbegue, L, Hichami, M, Hikem, Alaa, Hmad, Lina, Hmida, S, Hmissa, Makrem, Hochlaf, A, Houas, M, Houhani, Ali, Huwidi, Chau, Ian, B N, Ibrahim, Noha Y, Ibrahim, H, Idir, Dhilel, Issaoui, A, Itaimi, A E, Izem, Olfa, Jaidane, Daoud, Jamel, H, Jamous, Medsalah, Jarrar, Mohamed Salah, Jarrar, Saber, Jarray, M, Jebsi, Hafedh, Jmal, Abdallah, Juwid, Ons, Kaabia, A, Kablouti, Imene, Kacem, K, Kacem, M Y, Kaid, M, Kallel, R, Kallel, H, Kammoun, Syrjänen, Kari, Sarra, Karrit, Hela, Kchir, Nidhameddine, Kchir, T, Kebdani, N, Kechad, H, Kehili, E, Kerboua, Hassib, Keskes, Nora N, Kessi, N, Khababa, H, Khaldi, Afef, Khanfir, B, Khater, A, Khelif, S, Khemiri, K, Khennouf, H, Khouni, S, Khrouf, Zahra, Kmira, L, Kochbati, Asma, Korbi, N, Kouadri, F, Kouhen, M, Krarti, M, Handoussa, Yanzhi, Hsu, Ons, Laakom, Matti, Laato, Soumaya, Labidi, Fz, Lahlali, A, Lahmidi, A, Lalaoui, Naija, Lamia, A, Lamri, Feryel, Letaief, M R, Letaief, M, Aldehmani, A, Rafael, A M, Liepa, Faten, Limaiem, K, Limam, H, Loughlimi, F, Ltaief, Nadia, Maamouri, Mohamed, Mabrouk, R, Madouri, N, Mahjoub, Z, Mahjoubi, M, Mahrsi, Hochlef, Makrem, W, Mallek, Moez, Manitta, L, Mansoura, Houyem, Mansouri, Maher, Maoua, W, Maoui, Chakroun, Marouene, K, Marzouk, S, Masmoudi, Fatma, May, I, Meddeb, Khedija, Meddeb, S, Meddour, Fatma, Medhioub, Nesrine, Mejri, Mohamed Rochdi, Melizi, N, Mellas, Rihab, Melliti, A, Melzi, N, Merair, F Z, Merrouki, C, Mersali, O, Messalbi, Lina, Messaoudi, S, Messioud, K, Messoudi, Sarra, Mestiri, Amal, Mezlini, Amel, Mezlini, F, Mghirbi, H, Mhabrech, A, Mhiri, N, Midoun, Rabia, Milud, B, Missaoui, Aymen, Mnasser, Wafa, Mnejja, Moncef, Mokni, Amina, Mokrani, Mokrani, Mokrani, R, Moujahed, Y, Moukasse, A, Mouzount, Karima, Mrad, Mohamed Hedi, Mraidha, Nejib, Mrizak, Rafik, Mzali, Y, Mzid, F, M'ghirbi, Abdelwaheb, Nakhli, Chiraz, Nasr, Salsabil, Nasri, Gef, Noubigh, Daoud, Nouha, L, Nouia, Y, Nouira, A, Noureddine, O, Nouri, Atsushi, Ohtsu, H, Ouahbi, K, Oualla, Y, Ouanes, H, Ouaz, A, Ouikene, N, Ouldbessi, Iqbal, Parker, S, Pyrhonen, H, Rachdi, K, Rahal, Khaled, Rahal, M, Rahoui, Henda, Raies, Soumaya, Rameh, K, Reguieg, Haitham, Rejab, R, Rejiba, Mohamed Salah, Rhim, S, Riahi, N, Rouimel, N, Saad Saoud, K, Saadi, Myriam, Saadi, A, Sadou, Ines, Saguem, T, Sahnoun, H, Sahnoune, Saida, Sakhri, A, Sallemi, Asma, Sassi, W, Sbika, C, Sedkaoui, S, Sefiane, A, Sellami, Pyrhönen, Seppo, H, Sfaoua, Syrine, Sghaier, Ali, Shagan, W, Siala, I, Slim, M, Slimene, S, Soltani, S, Souilah, Marwa, Souissi, Badreddine, Sriha Badreddine, Youssef, Swaisi, A, Taibi, T, Taktak, Ghofran, Talbi, S W, Talha, Soha M, Talima, S, Tbessi, N, Tebani, S, Tebra, S, Tebramrad, D, Telaijia, A, Tenni, Ahmedou, Tolba, Yassen, Topov, K, Touil, Nabil, Toumi, W, Toumi, N, Tounsi, Aymen, Trigui, R, Trigui, W, Triki, Maroua, Walha, Ines, Werda, Haythem, Yacoub, Yosra, Yahyaoui, A, Yaich, R, Yaici, M, Yamouni, I, Yeddes, D, Yekrou, Ma, Yousfi, N, Yousfi, M A, Youssfi, L, Zaabar, Sonia, Zaied, I, Zaim, Walid, Zakhama, S, Zayed, Alia, Zehani, I, Zemni, Yosr, Zenzri, S, Zeraoula, O, Zouiten, Olfa, Zoukar, Ws, Zrafi, Aref, Zribi, and Naji, Zubia
- Published
- 2018
9. [Multilocular cystic renal cell carcinoma]
- Author
-
Faten, Farah-Klibi, Leila, Ferchichi, Abderrazek, Bouzouita, Mohamed, Sfaxi, Mohamed, Chebil, Sarrah, Baltagi Ben Jilani, and Rachida, Zermani
- Subjects
Adult ,Male ,Humans ,Kidney Diseases, Cystic ,Carcinoma, Renal Cell ,Kidney Neoplasms ,Aged - Abstract
Multilocular cystic renal cell carcinoma is an uncommon variant recently described of renal cell carcinoma.Analyze clinicopathological features, imaging findings and prognosis and therapeutic options of this tumor.The authors reported two cases of multilocular cystic renal cell carcinoma arising in 68 and 39-year-old men. They were admitted with pain in the lumbar region and/or haematuria. The imaging findings were a renal neoplasm with cystic and solid areas. The pathologic findings confirm the diagnosis of multilocular cystic renal cell carcinoma.Multilocular cystic renal cell carcinoma, usually identified at earlier stages, had slower growth rate and was therefore associated with a better prognosis and longer survival than conventional renal cell carcinoma.
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.